Loading...

Oncolytics Biotech: A Beacon of Hope in Cancer Treatment

Published
24 Feb 25
n/a
n/a
DailyInvestors's Fair Value
n/a
Loading
1Y
260.1%
7D
9.3%

Author's Valuation

SEK 2.56108.2% overvalued intrinsic discount

DailyInvestors's Fair Value